Latest News and Press Releases
Want to stay updated on the latest news?
-
PORTLAND, Ore., May 8, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today...
-
PORTLAND, Ore., May 6, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM) Chief Executive Officer Richard Sessions will speak today at the Pacific Northwest Life Sciences Meeting, being held in...
-
PORTLAND, Ore., April 15, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced...
-
PORTLAND, Ore., March 6, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced...
-
PORTLAND, Ore., Feb. 25, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today said it...
-
PORTLAND, Ore., Feb. 14, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced...
-
PORTLAND, Ore., Feb. 12, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced...
-
PORTLAND, Ore., Feb. 6, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today...
-
PORTLAND, Ore., Jan. 23, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced the...
-
PORTLAND, Ore., Jan. 4, 2008 (PRIME NEWSWIRE) -- Znomics, Inc., a pioneer in the development of the zebrafish as a simple vertebrate genetic platform to accelerate drug discovery, announced that its...